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AbstrACt 
Objectives Dengue is the most common viral mosquito-
borne disease, and women of reproductive age who live in 
or travel to endemic areas are at risk. Little is known about 
the effects of dengue during pregnancy on birth outcomes. 
The objective of this study is to examine the effect of 
maternal dengue severity on live birth outcomes.
Design and setting We conducted a population-based 
cohort study using routinely collected Brazilian data from 
2006 to 2012.
Participating We linked birth registration records and 
dengue registration records to identify women with and 
without dengue during pregnancy. Using multinomial 
logistic regression and Firth method, we estimated risk 
and ORs for preterm birth (<37 weeks’ gestation), low 
birth weight (<2500 g) and small for gestational age 
(<10thcentile). We also investigated the effect of time 
between the onset of the disease and each outcome.
results We included 16 738 000 live births. Dengue 
haemorrhagic fever was associated with preterm birth 
(OR=2.4; 95% CI 1.3 to 4.4) and low birth weight (OR=2.1; 
95% CI 1.1 to 4.0), but there was no evidence of effect for 
small for gestational age (OR=2.1; 95% CI 0.4 to 12.2). The 
magnitude of the effects was higher in the acute disease 
period.
Conclusion This study showed an increased risk of 
adverse birth outcomes in women with severe dengue 
during pregnancy. Medical intervention to mitigate 
maternal risk during severe acute dengue episodes may 
improve outcomes for infants born to exposed mothers.
IntrODuCtIOn
Dengue is the most common viral vector-
borne disease worldwide, with an estimated 
390 million people infected each year, 
96 million of whom develop clinical symp-
toms. It is endemic in over 100 countries 
(mostly in South and Central American and 
Southeast Asia) and is spreading to new areas; 
according to the WHO, approximately half of 
the world’s population is at risk.1 The effects 
of dengue during pregnancy are unclear, and 
there is a lack of evidence to inform women 
of reproductive age who live in or travel to 
endemic areas and who are at risk of dengue. 
The majority of studies published to date 
are cases series2; the seven studies published 
before 2016 with comparison groups show 
conflicting results,3–9 and a meta-analysis 
published in 2016 found dengue during 
pregnancy was only associated with low 
birth weight and preterm birth in symp-
tomatic women.2 In 2017, a large Brazilian 
study found that notification of mild dengue 
during pregnancy was not associated with 
higher rates of preterm birth or lower birth 
weight in neonates compared with rates in a 
random sample of all neonates. However, this 
study did not investigate the effects of dengue 
by severity or date of disease onset.10 
Maternal dengue, and specifically severe 
dengue, has been associated with fetal 
deaths,11 but the effects on those who survive 
has not been investigated in population-based 
study. We analysed a large, population-based 
cohort to investigate the association between 
symptomatic dengue notified during preg-
nancy and adverse birth outcomes and to 
examine the effect of maternal dengue 
severity.
strengths and limitations of this study
 ► This is the first study to investigate the risk of small 
for gestational age infants born to women with den-
gue during pregnancy using a population-based 
approach with a sufficiently large sample size and 
controlling for confounders.
 ► Due to sample size, we were able to investigate rare 
exposure (such as dengue haemorrhagic fever).
 ► This study relies on the use of secondary data, and 
therefore identification of the outcome and the expo-
sure is susceptible to misclassification.
 ► The linkage process was rigorously validated, and 
although we were unable to capture all cases, it is 
unlikely that the linkage process introduced bias, 
since linkage errors were not associated with any of 
our variables of interest.
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MethODs
We performed a population-based cohort study by linking 
routine records of live births with records of women noti-
fied and confirmed with dengue disease in Brazil from 
1 January 2006 to 31 December 2012. The methods 
described in this paper are similar to those used in a 
previously published paper about the effects of dengue 
on maternal deaths.12
Data sources
We used the following data from two Brazilian databases.
1. The Live Births Information System (Sistema de 
Informação sobre Nascimentos; SINASC), which re-
cords live births in Brazil; these data are derived from 
the birth registration, a legal document completed by 
the health worker who attended the birth. It includes 
information on the mother (name, place of residence, 
age, marital status and education); the pregnancy 
(length of gestation and mode of delivery); and the ne-
onate (birth weight and presence of congenital anom-
alies).13 Data completeness is very high, with 97% of 
Brazilian births registered,14 and most variables were 
>90% complete.15
2. Notifiable Diseases Information System (Sistema de 
Informação de Agravos de Notificação; SINAN), which 
records notifiable diseases. Dengue notifications in-
clude information on the individual (name, place of 
residence, age, sex and years of education), symptoms 
of the disease, laboratory tests and disease severity, as-
sessed clinically and by laboratory according with the 
Brazilian dengue manual.16 These data are reasonably 
complete on the variables used for linkage: <0.05% 
records were excluded because of a missing name. 
Around 5% of dengue cases did not have a final clas-
sification of severity. Laboratory confirmation was not 
required for notification or confirmation of dengue. 
During the study period (2006–2012), dengue was the 
main (and sometimes the only) vector-borne disease 
circulating in Brazil, as yellow fever and malaria oc-
curred in restricted areas, and Zika and Chikungunya 
did not begin to circulate until 2014.
Procedures
SINASC defines a live birth as the product of concep-
tion that, independent of the duration of pregnancy, 
breathes or shows any other signs of life (such as a heart-
beat, umbilical cord pulsation or definite movement of 
voluntary muscles), after the separation from the moth-
er’s body.13 We excluded live birth records from twin or 
other multiple pregnancies, congenital anomalies and 
records from municipalities without dengue notifications 
(figure 1).
Outcomes
We assessed three birth outcomes: preterm birth (<37 
weeks), low birth weight (<2500 g) and small for gesta-
tional age, calculated according to the Intergrowth Scale17 
using birth weight and gestational age in weeks at birth. 
This scale is sex specific, and those babies with a birth 
weight less than the 10th centile were considered small 
for gestational age. The data to calculate small for gesta-
tional age were available only for 2011 and 2012 (prior to 
this, gestational age was categorised).
exposure
We defined our exposure as confirmed cases of dengue 
notified to SINAN during a pregnancy that resulted in 
a live birth. In Brazil, confirmation of dengue is based 
either on clinical and epidemiological criteria (presence 
of clinical symptoms of dengue in the same area and time 
as other confirmed cases of dengue), or on clinical and 
laboratory criteria (the presence of clinical symptoms 
and a positive test for one of: (A) IgM detection by ELISA, 
(B) viral RNA detection via PCR, (C) NS1 viral antigen 
detection or (D) positive viral culture). We refer to labo-
ratory confirmed cases as ‘dengue during pregnancy, 
laboratory confirmed’. Dengue notifications do not 
always state whether the woman notified was pregnant; 
there is a field for this variable, but it is largely missing. 
We therefore defined maternal dengue cases by linking 
SINAN-confirmed dengue cases with live birth registra-
tions within the 9 months following disease notification. 
To categorise disease severity, we used the clinical classi-
fication valid in Brazil in the period in which data were 
collected, which classified dengue into three clinical 
categories: (A) ‘dengue fever’, (B) ‘complicated dengue’ 
and (C) ‘dengue haemorrhagic fever/dengue shock 
syndrome’. Dengue fever is a self-limiting disease, char-
acterised as fever, with a severe headache, pain behind 
the eyes, muscle and joint pain and rash. Complicated 
dengue is a probable case of dengue characterised by one 
of the following: severe changes in the nervous system, 
Figure 1 Flow chart with the linkage information Brazil, 
2006–2012.
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cardiorespiratory dysfunction, insufficient hepatic func-
tion, gastrointestinal bleeding, cavity spills or thrombocy-
topenia equal or less than 50 000/mm3 or leucometry less 
than 1000/mm18; dengue haemorrhagic fever follows the 
WHO criteria and is characterised by fever, haemorrhagic 
evidence, thrombocytopenia and evidence of plasma 
leakage. Complicated dengue is a Brazilian definition for 
severe cases of dengue that do not meet WHO criteria 
for dengue haemorrhagic fever and cannot be classified 
as mild self-limited disease (dengue fever) due to their 
severity.
Linkage process
We linked records of women with confirmed dengue 
(SINAN) with records of live births (SINASC) up to 
9 months after the SINAN notification to identify those 
mothers who had dengue during pregnancy. Since there 
was no unique identifier for linkage between the two data 
sources, we relied on a set of identifiers available with 
good data quality in both datasets: name, age or date of 
birth and the place of residence of the mother at time of 
delivery/time of notification. We excluded records with 
missing or implausible names (eg, the name of a hospital 
as the name of the mother) (figure 1).
We used probabilistic linkage, which generates match 
weights that represent the likelihood that two records 
belong to the same individual based on the similarity 
between records from different datasets. This linkage 
method takes into account errors and missing values in 
identifiers and is useful when there is no unique iden-
tifier. Match weight calculations used the Fellegi-Sunter 
method.19 For each record pair, we calculated a probabi-
listic match weight based on two conditional probabilities: 
m-probability, P (agreement|match) and u-probability, P 
(agreement|non-match). Match weights were calculated 
by summing the log of the ratio of m-probabilities and 
u-probabilities across different identifiers. The algorithm 
was implemented in Stata V.14.1 and R V.3.4.1.
Linkage followed the same procedure as previously 
described for linking stillbirth records and the dengue 
database in Brazil, in which we demonstrated a sensitivity 
(the proportion of true links captured) of 62% and a 
positive predictive value (the proportion of true matches 
among linked records) of 95%.20 To estimate parame-
ters for linkage weights and to validate the quality of the 
linkage, we created a gold standard dataset based on data 
from two states for 2010 Ceará and Espirito Santo). These 
states were chosen as they included a manageable number 
of records with which to conduct manual review different 
and represented a wide range of social economic status; 
2010 was chosen since this was dengue epidemic year. 
Record pairs were ordered by match weight and manually 
reviewed to establish true matches (records belonging 
to the same mother) and to identify any erroneous links 
(false matches). Live birth records linked to confirmed 
dengue notifications with high certainty were classified 
as dengue in pregnancy cases, and birth records we were 
confident had no link were classified as non-dengue 
cases. We excluded any records for which there was an 
uncertain link (where we could not establish whether a 
woman had dengue) to avoid misclassification (figure 1). 
Following linkage, the data were deidentified prior to 
analysis.
statistical analysis
We estimated the crude and adjusted risk ratios (RRs) and 
CIs from multinomial logistic regression. We compared 
live births from women without dengue during preg-
nancy (our reference group) with live births from women 
with notified dengue during pregnancy. We controlled 
for maternal age (categorised as ≤20; between 20–35 and 
≥35 years old), education (less than 3 years; between 4 
years and 7 years and more than 8 years) and marital 
status (single/widow/divorced or married/stable union), 
as these variables were also available in the data. To assess 
the sensitivity of results to the validity of clinical/epidemi-
ological diagnosis, we repeated the analyses using labora-
tory-confirmed dengue cases only.
In general, dengue is an acute disease with rapid 
recovery. However, we investigated the effect of time 
between disease onset and live birth outcomes. The time 
between disease onset and birth outcome was calculated 
using the date of the disease onset (information available 
in SINAN) and the date when the outcome occurred (date 
of live birth); we categorised this difference as being less 
than or equal to 10 days or greater than 10 days.
We also evaluated the association between dengue 
and birth outcomes according to severity of disease. The 
exposure was classified as mild dengue, dengue with 
complications and dengue haemorrhagic fever. For this 
analysis, we calculated the OR using the Firth method (to 
reduce the small sample bias in maximum likelihood esti-
mation) as we were analysing rare events and controlled 
for maternal age, education and marital status.21
Patient and public involvement
There were no patients involved in the research. The data 
used are administrative routinely collected data.
resuLts
A total of 20 333 482 live births were recorded in SINASC 
between 2006 and 2012. After exclusions, 16 738 000 live 
births were included in the study, and 17 673 (0.1%) of 
their mothers were linked with a dengue notification 
record (figure 1).
The cohort characteristics by dengue status are 
described in table 1. Compared with pregnant women 
without dengue, pregnant women with dengue were 
more likely to have more years of formal education and 
to have delivered by caesarean section.
Maternal dengue was associated with a slight increase 
in the risk of preterm birth (from 7.3% to 7.9%, RR 1.1; 
95% CI 1.0 to 1.2) and low birth weight (from 7.2% to 
8.4%, RR 1.2; 95% CI 1.1 to 1.2), although the CI was 
borderline. There was no association between maternal 
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Table 1 Maternal characteristics, delivery details and birth outcomes in relation to dengue status, Brazil, 2006–2012
Characteristics
Notified with confirmed dengue in 
pregnancy Without dengue notification
n (%) n (%)
Age of the mother (years)
  <20 4499 (25.5) 4 384 159 (26.2)
  20–35 11 981 (67.8) 11 042 342 (66.0)
  >35 1193 (6.7) 1 293 171 (7.8)
  Missing – 655 (0.0)
Maternal education
  Less than 3 years 1065 (6.1) 1 358 815 (8.3)
  4–7 years 4661 (27.0) 4 592 979 (28.1)
  More than 8 years 11 578 (66.9) 10 399 703 (63.6)
  Missing 369 (2.1) 368 830 (2.2)
Marital status
  Single/widow/divorced 11 518 (66.1) 9 660 306 (58.7)
  Married/union 5899 (33.9) 6 797 658 (41.3)
  Missing 256 (1.4) 262 363 (1.6)
Numbers of prenatal visits
  Inadequate (less than seven times) 6991 (39.9) 6 817 679 (41.2)
  Adequate (seven or more times) 10 515 (60.1) 9 712 338 (58.8)
  Missing 167 (0.9) 190 310 (1.1)
Delivery
  Vaginal 8332 (47.2) 8 383 714 (50.2)
  C-section 9320 (52.8) 8 307 072 (49.8)
  Missing 21 (0.1) 29 541 (0.2)
Gestational age in the delivery
  Less than 22 weeks 17 (0.1) 8844 (0.0)
  22–27 weeks 68 (0.4) 58 760 (0.4)
  28–31 weeks 147 (0.8) 112 407 (0.7)
  32–36 weeks 1157 (6.7) 1 011 633 (6.1)
  Total preterm birth 1389 (8.0) 1 191 644 (7.2)
  More than 37 weeks 15 994 (92.0) 15 215 440 (92.8)
  Missing 290 (1.6) 313 243 (1.9)
Birth weight
  ≥3000 12 171 (69.1) 11 659 487 (69.9)
  3000–2500 3973 (22.5) 3 816 201 (22.9)
  Total low birth weight 1484 (8.4) 15 475 688 (7.2)
  1500–2500 1258 (7.1) 1 026 248 (6.1)
  <1500 226 (1.3) 178 643 (1.1)
  Missing 38 (0.2) 39 748 (0.2)
Small for gestational age (10th centile)*
  Normal 3681 (91.7) 3 289 125 (92.0)
  Small 331 (8.2) 287 173 (8.0)
  Data not collected 13 661 (77.3) 13 144 029 (78.6)
*Data available only in 2011 and 2012.
†% of each category without the missing value.
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dengue and being small for gestational age (table 2). 
Restricting analyses to the 33%, (5755/17 388) of 
dengue cases that were laboratory confirmed did not 
change the magnitude of the associations (table 2).
Table 3 shows the dose–response effect of the severity 
of dengue on preterm birth, low birth weight and small 
for gestational age. Dengue haemorrhagic fever in 
pregnancy was associated with a doubling of the risk 
of preterm birth, from 1 191 644/16 407 084 (7.3%) 
to 12/79 (15.2%); OR 2.4 (95% CI 1.3 to 4.4) and an 
increase in the odds of low birth weight, from 1 204 
891/16 680 579 (7.2%) to 11/79 (13.9%); OR 2.1 (95% 
CI 1.1 to 4.0). We found no evidence for an effect of 
dengue on small for gestational age, even among preg-
nant women who developed haemorrhagic disease (287 
173/3 576 298 (8.0%) versus 1/9 (11.1%); OR 2.5 (95% 
CI 0.4 to 12.2).
There was some evidence that the risk of dengue in 
pregnancy on birth outcomes depended on the time 
between dengue onset and the date of live birth: the 
magnitude of the effect of dengue on adverse birth 
outcomes was higher during the acute disease period, 
with some residual effects remaining after the first 10 days 
for preterm birth and low birth weight (table 4).
Table 2 Number of cases notified with dengue during pregnancy (N), crude and adjusted risk ratio for the association among 
dengue during pregnancy and preterm birth, low birth weight and small for gestational age
All dengue cases Lab confirmed dengue cases
N
Crude Risk Ratio
(95% CI)
Adjusted Risk Ratio
(95% CI)
Crude Risk Ratio
(95% CI)
Adjusted Risk Ratio
(95% CI)
Preterm birth n=1 193 033
  Overall (<37 weeks) 1389 1.1 (1.0 to 1.2) 1.1 (1.0 to 1.2) 439 1.1 (1.0 to 1.2) 1.1 (1.0 to 1.2)
  Less than 28 weeks 1.1 (1.0 to 1.1) 1.1 (1.0 to 1.2) 1.0 (0.9 to 1.2) 1.0 (0.9 to 1.2)
  28–32 weeks 1.2 (1.1 to 1.5) 1.2 (1.1 to 1.4) 1.2 (0.9 to 1.6) 1.2 (0.9 to 1.6)
  32–36 weeks 1.2 (1.0 to 1.5) 1.1 (0.9 to 1.4) 1.1 (0.7 to 1.6) 1.1 (0.7 to 1.6)
Low birth weight n=1 206 375
  Overall (<2500 g) 1484 1.2 (1.1 to 1.2) 1.2 (1.1 to 1.2) 475 1.2 (1.0 to 1.3) 1.2 (1.1 to 1.3)
  1500–2499 g 1.2 (1.1 to 1.2) 1.2 (1.1 to 1.2) 1.2 (1.0 to 1.3) 1.2 (1.1 to 1.3)
  Less than 1500 g 1.2 (1.1 to 1.4) 1.2 (1.0 to 1.3) 1.1 (0.9 to 1.4) 1.1 (0.9 to 1.4)
Small for gestational age n=287 504
  <10th centile 331 1.0 (0.9 to 1.1) 1.0 (0.9 to 1.1) 68 0.9 (0.7 to 1.1) 0.9 (0.7 to 1.2)
Brazil, 2006 –2012. 
Adjusted for maternal age, education and marital status.
Table 3 Number of cases with dengue during pregnancy (N) and OR for the association dengue during pregnancy by severity 
of disease and adverse birth outcomes (preterm birth, low birth weight and small for gestational)
Outcome Dengue fever Complicated dengue Haemorrhagic fever 
Preterm birth (<37 weeks) n=1 192 920
  N (%) 1234 30 12 
  Crude OR (95% CI) 1.1 (1.0 to 1.1) 1.4 (0.9 to 1.9) 2.4 (1.3 to 4.3) 
  Adjusted OR (95% CI) 1.1 (1.0 to 1.1) 1.4 (0.9 to 2.0) 2.4 (1.3 to 4.4) 
Low birth weight (<2500 g) n=1 206 265
  N 1327 36 11
  Crude OR (95% CI) 1.1 (1.1 to 1.2) 1.6 (1.2 to 2.3) 2.1 (1.1 to 4.0)
  Adjusted OR (95% CI) 1.1 (1.1 to 1.2) 1. 6 (1.1 to 2.3) 2.1 (1.1 to 4.0)
Small for gestational age (10th centile) n=287 474
  N 294 6 1
  Crude OR (95% CI) 1.0 (0.9 to 1.1) 2.2 (0.9 to 5.1) 2.0 (0.3 to 11.4)
  Adjusted OR (95% CI) 1.0 (0.9 to 1.1) 2.3 (1.0 to 5.3) 2.1 (0.4 to 12.2)
Brazil, 2006–2012. 
Adjusted for maternal age, education and marital status.
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DIsCussIOn
Our study demonstrates that dengue haemorrhagic fever 
in pregnancy is associated with a doubling of the risk of 
preterm birth (OR: 2.4) and of low birth weight (OR: 
2.1) and that mild dengue fever is associated with an 
increase of 10%–20% in the risk of preterm birth and low 
birth weight, respectively. We found no evidence for an 
increased risk of small for gestational age for either severe 
or mild disease. The association between dengue and 
birth outcomes was strongest during the acute disease 
phase, within the first 10 days of disease onset.
Our results are consistent those with Nascimento et 
al,10 who showed that symptomatic dengue infection did 
not greatly affect the risk of low birth weight (OR: 1.00, 
95% CI 0.85 to 1.17) or preterm birth (OR: 0.98, 95% CI 
0.83 to 1.16) when compared with a random sample of 
live births. However, we have previously shown that mild 
dengue is associated with a doubling of the risk of still-
birth (and that severe cases are associated with a fivefold 
increase in risk). By considering only live birth outcomes 
and excluding births with congenital anomalies (<1% 
of the sample) in this study, we may be underestimating 
the effect of dengue during pregnancy. Our findings are 
also consistent with a meta-analyses published in 2016,2 
which found an association between symptomatic dengue 
and preterm birth and low birth weight within in a hospi-
tal-based population that sought care and was likely to 
include only severe dengue cases. In our study, the associ-
ation between maternal dengue and birth outcomes was 
strongest for women with dengue haemorrhagic fever in 
pregnancy.
There is evidence that different infectious diseases in 
pregnancy can lead to adverse outcomes. The evidence is 
still fragmented, and there is no consistent effect, which 
appears to vary according to the pathogen involved and 
the timing and severity of maternal disease. For instance, 
studies comparing pregnant women with infection to 
pregnant women without found: (A) severe influenza 
increased the risk of preterm birth from 2.4 to 4 times, 
whereas studies based on mild range of illness did not find 
an effect22 and (b) measles and HIV infection increased 
the risk of low birth weight by 3.5 and 1.6 times, respec-
tively.23 24
One mechanism by which dengue during pregnancy 
affects preterm birth and low birth weight that is consis-
tent with our results is through maternal illness, rather 
than a direct effect on the fetus. Since we did not observe 
an effect on small for gestational age, the effect of 
dengue in pregnancy on birth weight may have occurred 
via prematurity of the newborn. This assumption is 
supported by the higher risk of preterm births observed 
among mothers within less than 10 days after the onset 
of the disease and among those with complicated disease 
and haemorrhagic dengue. The higher risk of preterm 
birth could be due to the early onset of labour delivery 
or by early delivery due to medical interventions, such 
as caesarean section, required because of concern about 
risk to the mother. However, data on small for gestational 
age was only available for 2011–2012, which may have 
affected our ability to observe an effect. Furthermore, 
analysis according to mode of delivery is complicated due 
to high rates of caesarean section in Brazil, many of which 
are not clinically indicated.
Limitations of this study include the linkage process 
and use of secondary data. First, outcome and exposure 
identification is susceptible to misclassification using 
secondary sources. Preterm birth and small for gesta-
tional age are underascertained in routinely collected 
data from low-income and middle-income countries. 
However, as this is likely to have affected both those 
Table 4 Number of cases with dengue during pregnancy (N) and risk ratio (RR) for the association dengue during pregnancy 
by timing of disease and adverse birth outcomes (preterm birth, low birth weight and small for gestational)
Outcome
Outcomes within 10 days of disease onset
(95% CI)
Outcomes after 10 days from disease onset
(95% CI)
Preterm birth n=1 191 719
  N 75 1314
  Crude RR (95% CI) 2.1 (1.7 to 2.7) 1.1 (1.0 to 1.1)
  Adjusted RR (95% CI) 2.0 (1.6 to 2.6) 1.1 (1.0 to 1.1)
Low birth weight n=1 206 375
  N 74 1410
  Crude RR (95% CI) 2.1 (1.6 to 2.6) 1.1 (1.1 to 1.2)
  Adjusted RR (95% CI) 2.0 (1.6 to 2.6) 1.1 (1.1 to 1.2)
Small for gestational age (<10th centile) n=287 173
  N 4 83
  Crude RR (95% CI) 0.5 (0.2 to 1.5) 1.0 (0.9 to 1.1)
  Adjusted RR (95% CI) 0.5 (0.2 to 1.5) 1.0 (0.9 to 1.1)
Brazil, 2006–2012. 
Adjusted for maternal age, education and marital status.
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exposed and not exposed to dengue in a similar way, 
it is unlikely that results of this study would have been 
biased.25 26 Regarding the dengue diagnosis, it is usual 
practice in outbreaks/epidemics to test until the origin 
of the outbreak is clearly established and after that only 
test when there is a clinical indication. The proportion 
of laboratory confirmed cases among general popula-
tion in Brazil is around 30%,27 and therefore, misclassi-
fication based on the lack of laboratory confirmation is 
possible. However, our sensitivity analysis demonstrated 
similar results in subsets of the data with and without 
laboratory confirmation of dengue. Second, our linkage 
was rigorously validated in a previous study.19 Despite 
the low sensitivity (that kept us from making statements 
about the prevalence of dengue during pregnancy), it is 
unlikely that the linkage process introduced bias, since 
linkage errors occurred randomly within the data and 
were not associated with our variables of interest. Finally, 
although we adjusted for confounders, other possible 
unknown confounders, such as maternal comorbidities 
or quality or type of obstetric care, may have contributed 
to the association between severe dengue and adverse 
birth outcomes.
As dengue prevention is not straightforward and 
mosquito control has failed in Brazil, our findings high-
light the crucial role of the clinical management of 
dengue in pregnant women. Doctors and medical staff 
in general attending to pregnant women with dengue 
should closely observe and monitor the patients to be 
able to intervene timely and avoid adverse outcomes for 
mothers and babies, especially during the acute phase. 
We recommend careful observation and notation of 
dengue in antenatal records and further research into 
the association between dengue and adverse pregnancy 
outcomes.
In summary, this study demonstrates a doubling in the 
risk of preterm birth and low birth weight associated with 
dengue haemorrhagic fever in pregnancy and increases 
of 10%–20% in women with mild dengue. One contrib-
uting factor to adverse birth outcomes may be medical 
interventions triggered to mitigate mothers risk associ-
ated with dengue haemorrhagic fever. We recommend 
further research in different settings to confirm our 
results and additional studies of adverse birth outcomes 
for other vector-borne diseases.
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